Immatics (IMTX) Revenue (2019 - 2025)
Immatics (IMTX) posted Revenue of $23.0 million for Q4 2025, up 279.34% sequentially from $6.1 million in Q3 2025, and down 61.73% YoY from $60.1 million in Q4 2024.
Immatics (IMTX) Revenue (2019 - 2025) Analysis & Trends
Immatics has reported Revenue for 7 years, with the latest figure at $23.0 million in Q4 2025.
- Quarterly Revenue fell 61.73% year-over-year to $23.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54.0 million (down 68.01% YoY) and the FY2025 annual result came in at $54.5 million, down 67.67% from the prior year.
- Revenue grew to $23.0 million in Q4 2025 per IMTX's latest filing, from $6.1 million in the prior quarter.
- Over five years, Revenue peaked at $115.5 million in Q1 2022 and troughed at $5.4 million in Q2 2025.
- A 5-year average of $25.5 million and a median of $18.2 million in 2021 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue jumped 1193.39% in 2022, then tumbled 90.9% in 2023.
- Over 5 years, Revenue stood at $18.0 million in 2021, then surged by 113.49% to $38.4 million in 2022, then plunged by 55.4% to $17.1 million in 2023, then soared by 250.91% to $60.1 million in 2024, then slumped by 61.73% to $23.0 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $23.0 million, $6.1 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | 23.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.00 Mn |
| Sep 30, 2025 | 6.06 Mn |
| Jun 30, 2025 | 5.36 Mn |
| Mar 31, 2025 | 19.55 Mn |
| Dec 31, 2024 | 60.11 Mn |
| Sep 30, 2024 | 55.52 Mn |
| Jun 30, 2024 | 20.20 Mn |
| Mar 31, 2024 | 32.88 Mn |
| Dec 31, 2023 | 17.13 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 24.34 Mn |
| Mar 31, 2023 | 10.51 Mn |
| Dec 31, 2022 | 38.41 Mn |
| Sep 30, 2022 | 15.18 Mn |
| Jun 30, 2022 | 18.37 Mn |
| Mar 31, 2022 | 115.50 Mn |
| Dec 31, 2021 | 17.99 Mn |
| Sep 30, 2021 | 7.60 Mn |
| Jun 30, 2021 | 6.25 Mn |
| Mar 31, 2021 | 8.93 Mn |